|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1991-12-18
|
|
pubmed:abstractText |
To use meta-analysis to estimate the benefits of drug treatment to lower cholesterol levels in the primary and secondary prevention of coronary heart disease (CHD) events.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0025-729X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
18
|
|
pubmed:volume |
155
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
665-6, 669-70
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1834922-Aged,
pubmed-meshheading:1834922-Anticholesteremic Agents,
pubmed-meshheading:1834922-Cholesterol,
pubmed-meshheading:1834922-Coronary Disease,
pubmed-meshheading:1834922-Female,
pubmed-meshheading:1834922-Humans,
pubmed-meshheading:1834922-Male,
pubmed-meshheading:1834922-Meta-Analysis as Topic,
pubmed-meshheading:1834922-Middle Aged,
pubmed-meshheading:1834922-Odds Ratio,
pubmed-meshheading:1834922-Primary Prevention
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trials.
|
|
pubmed:affiliation |
University of Newcastle, Shortland, NSW.
|
|
pubmed:publicationType |
Journal Article,
Meta-Analysis
|
